Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2019 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Consultation on UTUC, Stockholm 2018: aspects of treatment.
Jung H, Giusti G, Fajkovic H, Herrmann T, Jones R, Straub M, Baard J, Osther PJS, Brehmer M. Jung H, et al. World J Urol. 2019 Nov;37(11):2279-2287. doi: 10.1007/s00345-019-02811-w. Epub 2019 May 23. World J Urol. 2019. PMID: 31123852 Free PMC article. Review.
Identification of tumor grade and stage is crucial when selecting treatment. Ureteroscopic management of low-grade and non-invasive UTUC achieves disease-free survival similar to that offered by radical nephroureterectomy but seems to be a risk factor for intravesic …
Identification of tumor grade and stage is crucial when selecting treatment. Ureteroscopic management of low-grade and non-invasiv
Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma.
McElree IM, Belzer A, Mott SL, Packiam VT, O'Donnell MA, Steinberg RL. McElree IM, et al. Urol Oncol. 2024 Jan;42(1):20.e9-20.e15. doi: 10.1016/j.urolonc.2023.08.013. Epub 2023 Oct 5. Urol Oncol. 2024. PMID: 37805338
PURPOSE: There is an unmet need for effective renal sparing treatments for upper tract urothelial carcinoma (UTUC). Gemcitabine/Docetaxel (Gem/Doce) has shown favorable efficacy in nonmuscle invasive bladder cancer. ...RESULTS: The final cohort included 31 patients with 41 …
PURPOSE: There is an unmet need for effective renal sparing treatments for upper tract urothelial carcinoma (UTUC). Gemcitabine/Docet …
Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA. Cutress ML, et al. BJU Int. 2012 Dec;110(11):1608-17. doi: 10.1111/j.1464-410X.2012.11169.x. Epub 2012 May 7. BJU Int. 2012. PMID: 22564677
and What does the study add? Endoscopic management of small, low-grade, non-invasive upper tract urothelial cell carcinoma (UTUC) is a management option for selected groups of patients. ...OBJECTIVE: To report the long-term outcomes of patients with up …
and What does the study add? Endoscopic management of small, low-grade, non-invasive upper tract urothelial cell